Home › Breast Cancer › NCT04022616
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
RecruitingObservational study
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * 18 years of age or older * Ability to give informed consent * Stage I-III breast malignancy Exclusion Criteria: * Unable to tolerate venipuncture
About the study
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
What is being tested
- Specimen collection (other)
Sponsor: Ohio State University Comprehensive Cancer Center · Participants: 99 · Started: Jun 4, 2010
Contact the study team
- Ohio State Comprehensive Cancer Center · Phone: 1-800-293-5066
Official record on ClinicalTrials.gov — NCT04022616
Locations in the U.S.
| Ohio | Ohio State University Comprehensive Cancer Center, Columbus |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.